1.2(top 50%)
impact factor
387(top 50%)
papers
12.1K(top 20%)
citations
46(top 20%)
h-index
1.3(top 50%)
extended IF
456
all documents
12.6K
doc citations
101(top 10%)
g-index
Top Articles
| # | Title | Journal | Year | Citations |
|---|---|---|---|---|
| 1 | El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 4,392 |
| 2 | A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 253 |
| 3 | A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2001 | 234 |
| 4 | Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 234 |
| 5 | Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 216 |
| 6 | Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 173 |
| 7 | Nutritional assessment and survival in ALS patients | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 167 |
| 8 | New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: Inclusions containing SOD1 in neurons and astrocytes | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 142 |
| 9 | Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 121 |
| 10 | Amyotrophic lateral sclerosis: A review of current concepts | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 118 |
| 11 | Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 108 |
| 12 | Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 106 |
| 13 | Subjective experience and coping in ALS | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2002 | 105 |
| 14 | Current status of SOD1 mutations in familial amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 104 |
| 15 | Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 104 |
| 16 | Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 103 |
| 17 | Correlates of Quality of Life in people with motor neuron disease (MND) | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2002 | 100 |
| 18 | Nutritional management in MND/ALS patients: an evidence based review | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 97 |
| 19 | ALSFRS‐R | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 96 |
| 20 | A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2001 | 95 |
| 21 | Nocturnal pulse oximetry: a new approach to establish the appropriate time for non‐invasive ventilation in ALS patients | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 95 |
| 22 | Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2001 | 87 |
| 23 | Gastrointestinal dysfunction in amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 85 |
| 24 | A survey of clinicians' practice in the symptomatic treatment of ALS | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 85 |
| 25 | Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2002 | 82 |
| 26 | Relevance of oxidative injury in the pathogenesis of motor neuron diseases | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 81 |
| 27 | A prospective, randomized, placebo‐controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 81 |
| 28 | Amyotrophic lateral sclerosis: toxins and environment | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 75 |
| 29 | A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 75 |
| 30 | Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40 | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 73 |
| 31 | Reduced NAA in motor and non‐motor brain regions in amyotrophic lateral sclerosis: a cross‐sectional and longitudinal study | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 73 |
| 32 | Breaking the news: A survey of ALS patients and their caregivers | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 72 |
| 33 | Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 67 |
| 34 | Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 65 |
| 35 | Cognitive impairment in motor neuron disease with bulbar onset | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2001 | 64 |
| 36 | Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2002 | 64 |
| 37 | Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999 | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 64 |
| 38 | Genetics of sporadic ALS | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2001 | 63 |
| 39 | Long-term safety of riluzole in amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2002 | 63 |
| 40 | Improving the quality of life for people with ALS: The challenge ahead | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 57 |
| 41 | The ALS Patient Care Database: Insights into End-of-Life Care in ALS | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2001 | 56 |
| 42 | The Neurophysiological Index in ALS | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 54 |
| 43 | Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 50 |
| 44 | Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 50 |
| 45 | Development and implementation of the Dutch protocol for rehabilitative management in amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 49 |
| 46 | Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2002 | 48 |
| 47 | Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 45 |
| 48 | Detection of Nε-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2002 | 41 |
| 49 | Non‐invasive ventilation in ALS: current practice and future role | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2004 | 41 |
| 50 | Genetic factors in the early diagnosis of ALS | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2000 | 40 |